Literature DB >> 12357376

Lack of p53 expression in human myeloid leukemias is not due to mutations in transcriptional regulatory regions of the gene.

S Durland-Busbice, D Reisman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12357376     DOI： 10.1038/sj.leu.2402647

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  16 in total

1.  Regulation of Endoribonuclease Activity of Alpha-Type Proteasome Subunits in Proerythroleukemia K562 Upon Hemin-Induced Differentiation.

Authors:  Alexey G Mittenberg; Tatyana N Moiseeva; Valeria O Kuzyk; Nickolai A Barlev
Journal:  Protein J       Date:  2016-02       Impact factor: 2.371

2.  Mutations in the TP53 gene affected recruitment of 53BP1 protein to DNA lesions, but level of 53BP1 was stable after γ-irradiation that depleted MDC1 protein in specific TP53 mutants.

Authors:  Jana Suchánková; Soňa Legartová; Eva Ručková; Bořivoj Vojtěšek; Stanislav Kozubek; Eva Bártová
Journal:  Histochem Cell Biol       Date:  2017-04-10       Impact factor: 4.304

3.  Gain of cellular adaptation due to prolonged p53 impairment leads to functional switchover from p53 to p73 during DNA damage in acute myeloid leukemia cells.

Authors:  Juni Chakraborty; Shuvomoy Banerjee; Pallab Ray; Dewan Md Sakib Hossain; Sankar Bhattacharyya; Arghya Adhikary; Sreya Chattopadhyay; Tanya Das; Gaurisankar Sa
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

4.  Synergistic effect of hydrogen peroxide on polyploidization during the megakaryocytic differentiation of K562 leukemia cells by PMA.

Authors:  Yoshihiro Ojima; Mark Thompson Duncan; Retno Wahyu Nurhayati; Masahito Taya; William Martin Miller
Journal:  Exp Cell Res       Date:  2013-06-13       Impact factor: 3.905

5.  Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignancies.

Authors:  Melissa A Fischer; Sharon Y Friedlander; Maria P Arrate; Hua Chang; Agnieszka E Gorska; Londa D Fuller; Haley E Ramsey; Trinayan Kashyap; Christian Argueta; Sophie Debler; Michael Byrne; Matthew T Villaume; Aaron C Shaver; William Senapedis; Yosef Landesman; Erkan Baloglu; Sharon Shacham; Michael R Savona
Journal:  Blood Adv       Date:  2020-02-11

6.  Optimizing and predicting the in vivo activity of AT9283 as a monotherapy and in combination with paclitaxel.

Authors:  Emad Y Moawad
Journal:  J Gastrointest Cancer       Date:  2015-12

7.  Novel levamisole derivative induces extrinsic pathway of apoptosis in cancer cells and inhibits tumor progression in mice.

Authors:  Mahesh Hegde; Subhas S Karki; Elizabeth Thomas; Sujeet Kumar; Kuppusamy Panjamurthy; Somasagara R Ranganatha; Kanchugarakoppal S Rangappa; Bibha Choudhary; Sathees C Raghavan
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

8.  Differential effects of polyphenols on proliferation and apoptosis in human myeloid and lymphoid leukemia cell lines.

Authors:  Amani A Mahbub; Christine L Le Maitre; Sarah L Haywood-Small; Gordon J McDougall; Neil A Cross; Nicola Jordan-Mahy
Journal:  Anticancer Agents Med Chem       Date:  2013-12       Impact factor: 2.505

9.  D(-)lentiginosine-induced apoptosis involves the intrinsic pathway and is p53-independent.

Authors:  A Minutolo; S Grelli; F Marino-Merlo; F M Cordero; A Brandi; B Macchi; A Mastino
Journal:  Cell Death Dis       Date:  2012-07-26       Impact factor: 8.469

10.  Propyl-2-(8-(3,4-difluorobenzyl)-2',5'-dioxo-8-azaspiro[bicyclo[3.2.1] octane-3,4'-imidazolidine]-1'-yl) acetate induces apoptosis in human leukemia cells through mitochondrial pathway following cell cycle arrest.

Authors:  Chandagirikoppal V Kavitha; Mridula Nambiar; Pavan B Narayanaswamy; Elizabeth Thomas; Ujjwal Rathore; Channapillekoppalu S Ananda Kumar; Bibha Choudhary; Kanchugarakoppal S Rangappa; Sathees C Raghavan
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.